Plitidepsin (also known as dehydrodidemnin B, marketed b...

wikipedia - 27 Jan 2021
Plitidepsin (also known as dehydrodidemnin B, marketed by PharmaMar, S.A. under the trade name Aplidin) is a chemical compound extracted from the ascidian Aplidium albicans.[1] It is currently undergoing clinical trial testing. It is a member of the class of compounds known as didemnins.

Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia ...

Nature.com - 13 Mar 2015
Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia ... ...

Plitidepsin, a molecule from sea squirts, could be a COVID-19 antiviral

Chemical & Engineering News - 28 Jan 2021
Plitidepsin, a molecule from sea squirts, could be a COVID-19 antiviral ...

Scientists hope they’re closing in on a cure for COVID-19

PBS NewsHour - 01 Jun 2021
Scientists hope they’re closing in on a cure for COVID-19 ...

Plitidepsin found to work better than remdesivir for treating COVID-19

Medical Xpress - 29 Jan 2021
Plitidepsin found to work better than remdesivir for treating COVID-19 ...

Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including B.1.1.7 Variant

UC San Francisco - 25 Jan 2021
Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including B.1.1.7 Variant ...

Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in ...

ScienceDirect.com - 06 Dec 2019
Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in ... ...

Cancer drug derived from sea squirts outperforms remdesivir in COVID-19 preclinical models

Fierce Biotech - 27 Jan 2021
Cancer drug derived from sea squirts outperforms remdesivir in COVID-19 preclinical models ...

A Deluge of New Drugs for COVID

Scientific American - 19 May 2022
A Deluge of New Drugs for COVID ...

Conflict of interest?

European Biotechnology News - 03 May 2023
Conflict of interest? ...

CHMP rejects plitidepsin again

MDedge - 28 Mar 2018
CHMP rejects plitidepsin again ...

PharmaMar Presents Positive Results of the Pivotal Phase III Trial with Plitidepsin in Multiple Myeloma During the ASH ...

PR Newswire - 11 Dec 2017
PharmaMar Presents Positive Results of the Pivotal Phase III Trial with Plitidepsin in Multiple Myeloma During the ASH ... ...

Plitidepsin